Biocartis S.a.
Patents = 10
Trademarks = 2
Forward Citations = 81
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
44 inventors (with patents filed for the assignee):
Biocartis S.a. is a Swiss molecular diagnostics company focused on developing and commercializing innovative diagnostic solutions to improve patient outcomes. The company's flagship product is the Idylla platform, a fully automated molecular diagnostics system that provides fast and accurate results for a wide range of cancer and infectious disease tests. Biocartis is dedicated to helping healthcare providers deliver personalized medicine and targeted therapies to their patients.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com